Ocular allergy and mast cell stabilizers
Identifieur interne : 004D45 ( Main/Exploration ); précédent : 004D44; suivant : 004D46Ocular allergy and mast cell stabilizers
Auteurs : Mathea R. Allansmith [États-Unis] ; Robert N. Ross [États-Unis]Source :
- Survey of Ophthalmology [ 0039-6257 ] ; 1986.
English descriptors
- Teeft :
- Albino rabbit, Allansmith, Allergen, Allergic, Allergic conditions, Allergic conjunctivitis, Allergic rhinitis, Allergy, Antihistamine, Arch ophthalmol, Atopic, Atopic keratoconjunctivitis, Basophil, Chief symptoms, Clin, Clinical trial, Conjunctiva, Conjunctival, Conjunctivitis, Cornea, Cornea1, Corticosteroid, Cromoglycate, Cromolyn, Cromolyn sodium, Cromolyn sodium therapy, Cromolyn sodium treatment, Degranulation, Differential diagnosis, Disodium cromoglycate, Eosinophil, Epithelium, Fever conjunctivitis, Gastrointestinal tract, Giant papillae, Histamine, Hypersensitivity, Inflammation, Keratitis, Keratoconjunctivitis, Limbal, Mast, Mast cell, Mast cell degranulation, Mast cell membrane, Mast cell stabilizers, Mast cells, Mediator, Nasal, Nasal symptoms, Ocular, Ocular allergies, Ocular allergy, Ocular surface, Ocular tissues, Ophthalmic, Ophthalmic solution, Ophthalmol, Ophthalmol clin, Papilla, Pathogenetic, Pathogenetic factors, Pepys, Pitman, Placebo, Placebo group, Proc, Propria, Punctate, Ragweed, Receptor, Rhinitis, Significant improvement, Sodium, Sodium cromoglycate, Stabilizer, Steroid, Substantia, Substantia propria, Surv, Surv ophthalmol, Symp, Symp davos, Symptom, Tarsal, Upper tarsal conjunctiva, Vernal, Vernal conjunctivitis, Vernal keratoconjunctivitis, Vernal keratoconjunctivitis patients.
Abstract
Abstract: The role of the mast cell in ocular allergy is becoming understood. As a result, the therapeutic effects of agents that stabilize the mast cell have been evaluated in the treatment of seasonal allergic conjunctivitis, vernal keratoconjunctivitis, atopic keratoconjunctivitis, and giant papillary conjunctivitis. At present, cromolyn sodium is the only available mast cell stabilizer of known effectiveness. Clinical and laboratory investigations of the effectiveness of cromolyn sodium in the treatment of ocular allergy are reviewed in the present article.
Url:
DOI: 10.1016/0039-6257(86)90119-0
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002706
- to stream Istex, to step Curation: 002706
- to stream Istex, to step Checkpoint: 002218
- to stream Main, to step Merge: 004E25
- to stream Main, to step Curation: 004D45
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Ocular allergy and mast cell stabilizers</title>
<author><name sortKey="Allansmith, Mathea R" sort="Allansmith, Mathea R" uniqKey="Allansmith M" first="Mathea R." last="Allansmith">Mathea R. Allansmith</name>
</author>
<author><name sortKey="Ross, Robert N" sort="Ross, Robert N" uniqKey="Ross R" first="Robert N." last="Ross">Robert N. Ross</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:3BBB42C6BF7768AB44141D7ACC0978003FF677D8</idno>
<date when="1986" year="1986">1986</date>
<idno type="doi">10.1016/0039-6257(86)90119-0</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-WVK59Q3N-C/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002706</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002706</idno>
<idno type="wicri:Area/Istex/Curation">002706</idno>
<idno type="wicri:Area/Istex/Checkpoint">002218</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002218</idno>
<idno type="wicri:doubleKey">0039-6257:1986:Allansmith M:ocular:allergy:and</idno>
<idno type="wicri:Area/Main/Merge">004E25</idno>
<idno type="wicri:Area/Main/Curation">004D45</idno>
<idno type="wicri:Area/Main/Exploration">004D45</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Ocular allergy and mast cell stabilizers</title>
<author><name sortKey="Allansmith, Mathea R" sort="Allansmith, Mathea R" uniqKey="Allansmith M" first="Mathea R." last="Allansmith">Mathea R. Allansmith</name>
<affiliation wicri:level="3"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Eye Research Institute of Retina Foundation, Boston</wicri:regionArea>
<placeName><settlement type="city">Boston</settlement>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ross, Robert N" sort="Ross, Robert N" uniqKey="Ross R" first="Robert N." last="Ross">Robert N. Ross</name>
<affiliation wicri:level="3"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Eye Research Institute of Retina Foundation, Boston</wicri:regionArea>
<placeName><settlement type="city">Boston</settlement>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Survey of Ophthalmology</title>
<title level="j" type="abbrev">SOP</title>
<idno type="ISSN">0039-6257</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1986">1986</date>
<biblScope unit="volume">30</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="229">229</biblScope>
<biblScope unit="page" to="244">244</biblScope>
</imprint>
<idno type="ISSN">0039-6257</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0039-6257</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Albino rabbit</term>
<term>Allansmith</term>
<term>Allergen</term>
<term>Allergic</term>
<term>Allergic conditions</term>
<term>Allergic conjunctivitis</term>
<term>Allergic rhinitis</term>
<term>Allergy</term>
<term>Antihistamine</term>
<term>Arch ophthalmol</term>
<term>Atopic</term>
<term>Atopic keratoconjunctivitis</term>
<term>Basophil</term>
<term>Chief symptoms</term>
<term>Clin</term>
<term>Clinical trial</term>
<term>Conjunctiva</term>
<term>Conjunctival</term>
<term>Conjunctivitis</term>
<term>Cornea</term>
<term>Cornea1</term>
<term>Corticosteroid</term>
<term>Cromoglycate</term>
<term>Cromolyn</term>
<term>Cromolyn sodium</term>
<term>Cromolyn sodium therapy</term>
<term>Cromolyn sodium treatment</term>
<term>Degranulation</term>
<term>Differential diagnosis</term>
<term>Disodium cromoglycate</term>
<term>Eosinophil</term>
<term>Epithelium</term>
<term>Fever conjunctivitis</term>
<term>Gastrointestinal tract</term>
<term>Giant papillae</term>
<term>Histamine</term>
<term>Hypersensitivity</term>
<term>Inflammation</term>
<term>Keratitis</term>
<term>Keratoconjunctivitis</term>
<term>Limbal</term>
<term>Mast</term>
<term>Mast cell</term>
<term>Mast cell degranulation</term>
<term>Mast cell membrane</term>
<term>Mast cell stabilizers</term>
<term>Mast cells</term>
<term>Mediator</term>
<term>Nasal</term>
<term>Nasal symptoms</term>
<term>Ocular</term>
<term>Ocular allergies</term>
<term>Ocular allergy</term>
<term>Ocular surface</term>
<term>Ocular tissues</term>
<term>Ophthalmic</term>
<term>Ophthalmic solution</term>
<term>Ophthalmol</term>
<term>Ophthalmol clin</term>
<term>Papilla</term>
<term>Pathogenetic</term>
<term>Pathogenetic factors</term>
<term>Pepys</term>
<term>Pitman</term>
<term>Placebo</term>
<term>Placebo group</term>
<term>Proc</term>
<term>Propria</term>
<term>Punctate</term>
<term>Ragweed</term>
<term>Receptor</term>
<term>Rhinitis</term>
<term>Significant improvement</term>
<term>Sodium</term>
<term>Sodium cromoglycate</term>
<term>Stabilizer</term>
<term>Steroid</term>
<term>Substantia</term>
<term>Substantia propria</term>
<term>Surv</term>
<term>Surv ophthalmol</term>
<term>Symp</term>
<term>Symp davos</term>
<term>Symptom</term>
<term>Tarsal</term>
<term>Upper tarsal conjunctiva</term>
<term>Vernal</term>
<term>Vernal conjunctivitis</term>
<term>Vernal keratoconjunctivitis</term>
<term>Vernal keratoconjunctivitis patients</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: The role of the mast cell in ocular allergy is becoming understood. As a result, the therapeutic effects of agents that stabilize the mast cell have been evaluated in the treatment of seasonal allergic conjunctivitis, vernal keratoconjunctivitis, atopic keratoconjunctivitis, and giant papillary conjunctivitis. At present, cromolyn sodium is the only available mast cell stabilizer of known effectiveness. Clinical and laboratory investigations of the effectiveness of cromolyn sodium in the treatment of ocular allergy are reviewed in the present article.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Massachusetts</li>
</region>
<settlement><li>Boston</li>
</settlement>
</list>
<tree><country name="États-Unis"><region name="Massachusetts"><name sortKey="Allansmith, Mathea R" sort="Allansmith, Mathea R" uniqKey="Allansmith M" first="Mathea R." last="Allansmith">Mathea R. Allansmith</name>
</region>
<name sortKey="Ross, Robert N" sort="Ross, Robert N" uniqKey="Ross R" first="Robert N." last="Ross">Robert N. Ross</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004D45 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004D45 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:3BBB42C6BF7768AB44141D7ACC0978003FF677D8 |texte= Ocular allergy and mast cell stabilizers }}
This area was generated with Dilib version V0.6.33. |